Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adults |
Dose: Form – Not for adult Note: Not for adult |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Active immunisation against pneumococcal disease Age: Infant 6 weeks to 6 months |
Dose: Intramuscular Injection – 0.5 mL Note: 3-dose primary series; 1st dose given at 2 months or at 6 weeks of age, with 1-month interval between doses; a booster dose is recommended at least 6 months after the last priming dose |
|
Indication: Active immunisation against pneumococcal disease Age: Infant 6 weeks to 6 months |
Dose: Intramuscular Injection – 0.5 mL Note: 2-dose primary series; 2 doses with the 1st dose given at 2 months of age, with 2-month interval between 1st and 2nd dose |
Administration
- Give as intramuscular injection
- Inject in deltoid or thigh
Side Effect
- Local Injection site reactions
- warmth
- erythema & swelling
- fever
- headache
- malaise
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Immunosuppressants (Cyclosporine, Tacrolimus, Mycophenolate, Azathioprine)
|
Adequate response may not be elicited
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe febrile illness
|
Postpone vaccination
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store refrigerated at 2° to 8°C. Protect vials from light.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.